BS
Therapeutic Areas
Innovative Cardiovascular Solutions Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Emblok 360° | Embolic Protection during Transcatheter Aortic Valve Replacement (TAVR) and other left-heart procedures | Pre-clinical |
Leadership Team at Innovative Cardiovascular Solutions
BB
Brad Brown
Chief Executive Officer
JC
Joel Crater
EVP, Business Development and Therapy
CT
Charles Tribie
EVP, Manufacturing
JM
Jeremy Moyer
Director of Clinical Affairs